Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen Yuliang

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Critical Reviews in Oncology/Hematology|February 21, 2024
A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?Liang Zhen, Wang Juan, Feng Tianrui, et al.
European Journal of Medical Research|June 2, 2023
The direct prognosis comparison of Zhen Liang, Chen Yuliang, Ming Zhu, et al.
European Journal of Medical Research|September 10, 2022
Comparison of malignancy and spatial distribution between latent and clinical prostate cancer: an 8-year biopsy studyLiang Zhen, Zhou Zhien, Huang Hanzi, et al.
Andrologia|July 28, 2021
Can patients with low-risk prostate cancer really benefit from radical treatment?: A systematic review and network meta-analysisLiang Zhen, Zhou Zhien, Yang Shengmin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Critical Reviews in Oncology/Hematology|February 21, 2024
A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?Liang Zhen, Wang Juan, Feng Tianrui, et al.
European Journal of Medical Research|June 2, 2023
The direct prognosis comparison of Zhen Liang, Chen Yuliang, Ming Zhu, et al.
European Journal of Medical Research|September 10, 2022
Comparison of malignancy and spatial distribution between latent and clinical prostate cancer: an 8-year biopsy studyLiang Zhen, Zhou Zhien, Huang Hanzi, et al.
Andrologia|July 28, 2021
Can patients with low-risk prostate cancer really benefit from radical treatment?: A systematic review and network meta-analysisLiang Zhen, Zhou Zhien, Yang Shengmin, et al.
Pageof 1